Victoza
Victoza (pronunciation: vik-TOE-zah) is a brand name for the drug liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes and obesity.
Etymology
The name Victoza is a proprietary name, likely derived from a combination of words related to victory and glucose, symbolizing its role in achieving victory over high blood sugar levels.
Usage
Victoza is used along with diet and exercise to improve blood sugar control in adults and children who are 10 years of age and older with type 2 diabetes mellitus. It is also used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes mellitus who are at high risk of such events.
Mechanism of Action
Victoza works by mimicking the functions of natural incretin hormones in the body that help keep blood sugar levels balanced. It stimulates the release of insulin, a hormone that lowers blood sugar levels, and inhibits the release of glucagon, a hormone that raises blood sugar levels.
Side Effects
Common side effects of Victoza include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation. Serious side effects may include pancreatitis, gallbladder disease, renal impairment, and hypersensitivity reactions.
Related Terms
- Liraglutide
- Type 2 diabetes
- Obesity
- Incretin
- Insulin
- Glucagon
- Pancreatitis
- Gallbladder disease
- Renal impairment
- Hypersensitivity reactions
External links
- Medical encyclopedia article on Victoza
- Wikipedia's article - Victoza
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski